http://www.thehindu.com/news/cities/Hyderabad/Fungal-infection-drug/article14023970.ece

Aurobindo Pharma has received US Food and Drug Administration (USFDA) approval to manufacture and market Voriconazole tablets (50 mg and 200 mg) that are used to treat fungal infections.Announcing this on Wednesday, the company said it expected be launch the product by March. The approved Abbreviated New Drug Application (ANDA) is bioequivalent and therapeutically equivalent to the reference listed drug product VFEND tablets of PF Prism C.V. This is the 59{+t}{+h}ANDA to be approved out of Aurobindo Pharmaâ€™s Unit VII formulation facility in Hyderabad for manufacturing oral non-antibiotic products.